Irish Health Repository >
Hospital Research >
Mercy University Hospital >
Preclinical evaluation of gene delivery methods for the treatment of loco-regional disease in breast cancer.
|Files in This Item:|
There are no files associated with this item.
|Title: ||Preclinical evaluation of gene delivery methods for the treatment of loco-regional disease in breast cancer.|
|Affiliation: ||Cork Cancer Research Centre, Mercy University Hospital and Leslie C Quick Jnr., Laboratory, University College Cork, Cork, Ireland.|
|Citation: ||Exp Biol Med (Maywood). 2011 Apr 1;236(4):423-34. Epub 2011 Mar 28.|
|Journal: ||Experimental biology and medicine (Maywood, N.J.)|
|Issue Date: ||31-Jan-2012 |
|PubMed ID: ||21444371|
|Abstract: ||Preclinical results with various gene therapy strategies indicate significant potential for new cancer treatments. However, many therapeutics fail at clinical trial, often due to differences in tissue physiology between animal models and humans, and tumor phenotype variation. Clinical data relevant to treatment strategies may be generated prior to clinical trial through experimentation using intact patient tissue ex vivo. We developed a novel tumor slice model culture system that is universally applicable to gene delivery methods, using a realtime luminescence detection method to assess gene delivery. Methods investigated include viruses (adenovirus [Ad] and adeno-associated virus), lipofection, ultrasound (US), electroporation and naked DNA. Viability and tumor populations within the slices were well maintained for seven days, and gene delivery was qualitatively and quantitatively examinable for all vectors. Ad was the most efficient gene delivery vector with transduction efficiency >50%. US proved the optimal non-viral gene delivery method in human tumor slices. The nature of the ex vivo culture system permitted examination of specific elements. Parameters shown to diminish Ad gene delivery included blood, regions of low viability and secondary disease. US gene delivery was significantly reduced by blood and skin, while tissue hyperthermia improved gene delivery. US achieved improved efficacy for secondary disease. The ex vivo model was also suitable for examination of tissue-specific effects on vector expression, with Ad expression mediated by the CXCR4 promoter shown to provide a tumor selective advantage over the ubiquitously active cytomegalovirus promoter. In conclusion, this is the first study incorporating patient tissue models in comparing gene delivery from various vectors, providing knowledge on cell-type specificity and examining the crucial biological factors determining successful gene delivery. The results highlight the importance of in-depth preclinical assessment of novel therapeutics and may serve as a platform for further testing of current, novel gene delivery approaches.|
|ISSN: ||1535-3699 (Electronic)|
|Appears in Collections: ||Mercy University Hospital|
this identifier to cite or link
to this item:
|Related articles on PubMed|
Preclinical evaluation of transcriptional targeting strategies for carcinoma of the breast in a tissue slice model system.
Stoff-Khalili MA, Stoff A, Rivera AA, Banerjee NS, Everts M, Young S, Siegal GP, Richter DF, Wang M, Dall P, Mathis JM, Zhu ZB, Curiel DT
A novel ex vivo model system for evaluation of conditionally replicative adenoviruses therapeutic efficacy and toxicity.
Kirby TO, Rivera A, Rein D, Wang M, Ulasov I, Breidenbach M, Kataram M, Contreras JL, Krumdieck C, Yamamoto M, Rots MG, Haisma HJ, Alvarez RD, Mahasreshti PJ, Curiel DT
2004 Dec 15
|See all 86 articles|
All Items in LENUS are protected by copyright, with all rights reserved, unless otherwise indicated.